Contents
What is Zepbound?
Zepbound is a brand-name prescription medication manufactured by Eli Lilly. Its active ingredient is tirzepatide, a dual GIP and GLP-1 receptor agonist. Zepbound is FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition. It also received FDA approval in 2024 for treating moderate-to-severe obstructive sleep apnea in adults with obesity.
Zepbound Dosing Schedule
Zepbound uses the same dosing schedule as Mounjaro — starting at 2.5mg and escalating in 2.5mg steps every 4 weeks up to a maximum of 15mg.
Dose Escalation Schedule
💡 You don't need to reach 15mg. The 5mg dose alone produces ~15% weight loss. Escalate only as fast as your tolerability allows — rushing escalation increases nausea without meaningfully accelerating long-term results.
Clinical Trial Results
| Trial | Dose | Duration | Avg Weight Loss | ≥20% Lost |
|---|---|---|---|---|
| SURMOUNT-1 (no T2D) | 5mg | 72 wks | 15.0% | 31% |
| SURMOUNT-1 (no T2D) | 10mg | 72 wks | 19.5% | 50% |
| SURMOUNT-1 (no T2D) | 15mg | 72 wks | 20.9% | 63% |
| SURMOUNT-2 (with T2D) | 15mg | 72 wks | 15.7% | — |
| SURMOUNT-3 (+ lifestyle) | 15mg | 72 wks | 26.6% | ~70% |
| SURMOUNT-5 vs Wegovy | Max dose | 72 wks | 20.2% vs 13.7% | — |
💡 SURMOUNT-3's 26.6% result included a 12-week intensive lifestyle lead-in before starting tirzepatide. This represents the ceiling of what's achievable combining optimal lifestyle with maximum-dose tirzepatide — approaching the results of bariatric surgery.
LillyDirect Vials — Best Self-Pay Option in 2026
Eli Lilly offers Zepbound single-dose vials directly to self-pay patients through LillyDirect.com — the most affordable FDA-approved GLP-1 option currently available in the US.
What You Need to Know About the Vials
- Same tirzepatide molecule as the autoinjector pen — identical efficacy
- Requires a separate syringe and needle to draw and inject (not a click-pen)
- Requires a valid US prescription — obtainable from your doctor or a telehealth provider
- Available at lillydirect.com
- Cannot be combined with commercial insurance — self-pay only
- Single-dose vials: use the entire vial immediately after opening
⚠️ The vials require manually drawing medication into a syringe rather than using a click-pen. If you're new to injections, ask your doctor or pharmacist for a brief demonstration before your first use.
Side Effects
Zepbound has a notably better tolerability profile than semaglutide (Wegovy/Ozempic), making it easier to stay on long-term.
| Side Effect | Zepbound Rate | Wegovy Rate |
|---|---|---|
| Nausea | ~18% | ~44% |
| Diarrhea | ~17% | ~30% |
| Vomiting | ~9% | ~24% |
| Constipation | ~11% | ~24% |
🚨 Do not use Zepbound if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2. Stop use and contact your doctor immediately if you experience severe abdominal pain, vision changes, or a lump or pain in the neck.
Cost & Insurance
| Coverage Type | Monthly Cost |
|---|---|
| List price (autoinjector pen) | ~$1,060/month |
| Commercial insurance + Lilly savings card | As low as $25/month |
| LillyDirect self-pay vials (2.5/5mg) | ~$349/month |
| LillyDirect self-pay vials (7.5/10mg) | ~$499/month |
| LillyDirect self-pay vials (12.5/15mg) | ~$549/month |
| Lilly patient assistance (uninsured, low income) | Free |
Zepbound vs Wegovy
| Feature | Zepbound | Wegovy |
|---|---|---|
| Active ingredient | Tirzepatide | Semaglutide |
| Mechanism | Dual GIP + GLP-1 | GLP-1 only |
| Avg weight loss (max dose) | 20.9% | 14.9% |
| Head-to-head difference | +47% more loss | (SURMOUNT-5) |
| Nausea rate | ~18% | ~44% |
| Best self-pay price | ~$349/mo (vials) | ~$1,349/mo |
Zepbound vs Mounjaro
Zepbound and Mounjaro are the same medication. Both contain tirzepatide at identical doses. The only difference is the FDA-approved indication:
- Zepbound → FDA-approved for weight management and sleep apnea. Use if you're treating obesity without diabetes, or if your insurance covers obesity medications.
- Mounjaro → FDA-approved for type 2 diabetes. Use if you have T2D, or if your insurance covers diabetes medications.
Your prescriber will choose the brand name based on your diagnosis and which insurance pathway provides better coverage.